| |
| |
|
| Insider
Information: |
Luly Jay R. |
| Relationship: |
President and CEO, Dir... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
810,609 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,991,858 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
810,609 |
|
|
| Total
Value |
$10,991,858 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 31.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
President and CEO, Dir... |
2024-02-12 |
810,609 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2024-02-12 |
4 |
D |
$12.41 |
$19,657 |
D/D |
(1,584) |
810,609 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,400 |
812,193 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-12-05 |
4 |
S |
$9.63 |
$69,625 |
D/D |
(7,230) |
806,793 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-12-01 |
4 |
D |
$9.49 |
$54,919 |
D/D |
(5,787) |
814,023 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-03-13 |
4 |
AS |
$44.81 |
$1,260,628 |
D/D |
(27,912) |
819,810 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-03-13 |
4 |
OE |
$14.00 |
$390,768 |
D/D |
27,912 |
847,722 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4/A |
A |
$0.00 |
$0 |
D/D |
52,096 |
840,401 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4/A |
D |
$52.77 |
$1,086,587 |
D/D |
(20,591) |
819,810 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
31,505 |
819,810 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4 |
D |
$52.77 |
$1,086,587 |
D/D |
(20,591) |
799,219 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-19 |
4 |
OE |
$27.58 |
$399,910 |
D/D |
14,500 |
788,305 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-16 |
4 |
AS |
$43.59 |
$1,341,713 |
D/D |
(30,000) |
773,805 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-16 |
4 |
OE |
$14.00 |
$422,907 |
D/D |
30,000 |
803,805 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-01 |
4 |
D |
$44.33 |
$250,863 |
D/D |
(5,659) |
773,805 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
63,000 |
779,464 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• – – |
2022-02-14 |
4 |
D |
$62.49 |
$147,164 |
D/D |
(2,355) |
716,464 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,028 |
718,819 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-01-15 |
4 |
OE |
$11.77 |
$118,442 |
D/D |
10,063 |
710,791 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2021-12-01 |
4 |
D |
$87.68 |
$170,450 |
D/D |
(1,944) |
700,728 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2021-09-15 |
4 |
AS |
$59.06 |
$266,698 |
D/D |
(4,516) |
676,972 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
683,689 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-12-15 |
4 |
D |
$42.52 |
$93,587 |
D/D |
(2,201) |
681,488 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
676,189 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-02-12 |
4 |
D |
$52.76 |
$164,717 |
D/D |
(3,122) |
649,689 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,395 |
652,811 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
